Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma

Varování

Publikace nespadá pod Ekonomicko-správní fakultu, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

STRAKA Matej ROHAN Tomáš MATKULČÍK Peter HUSTÝ Jakub ANDRAŠINA Tomáš

Rok publikování 2022
Druh Další prezentace na konferencích
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Purpose: To analyze whether transarterial chemoembolization (TACE) using degradable starch microspheres (DSM-TACE) or permanent embolizing particles (DEB-TACE) cause significant difference in rate of major periprocedural complications in patients with hepatocellular carcinoma (HCC). Materials and methods: Prospective assessment of major periprocedural complications in 226 TACE procedures between 2018-2021 in 57 consecutive patients with HCC was performed. Study group consists of 110 DSM-TACE procedures, the control group consists of 116 procedures using permanent embolizing particles. Major complications were followed up to 30 days after each TACE (contrast-enhanced CT, laboratory parameters, clinical status). Our data underwent statical analyses (chi-squared test). Results: There was significant difference in complication per procedure in the study and the control group (3% vs 14% p=0,006). Complications after TACE included severe postembolization syndrome (n=11), liver ischemia caused by reflux of permanent particles (n=4), liver abscess (n=2), cholangitis (n=2), allergic reaction (n=1). Conclusion: Patients with HCC treated with TACE using permanent embolization particles have significantly higher frequency of major postprocedural complication compared to patients with HCC treated with TACE using degradable particles.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.